This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ONCR Oncorus (ONCR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Oncorus Stock (NASDAQ:ONCR) 30 days 90 days 365 days Advanced Chart Get Oncorus alerts:Sign Up Key Stats Today's Range$0.13▼$0.2050-Day Range$0.01▼$0.1352-Week Range$0.01▼$0.47Volume135,947 shsAverage Volume1.33 million shsMarket Capitalization$3.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts. Read More Receive ONCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncorus and its competitors with MarketBeat's FREE daily newsletter. Email Address ONCR Stock News HeadlinesRFL Rafael Holdings, Inc.August 1, 2024 | seekingalpha.comOncorus Inc rdinary Shares Stock (OTC:ONCR) Dividends: History, Yield and DatesFebruary 26, 2024 | benzinga.com[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.July 16 at 2:00 AM | Crypto Swap Profits (Ad)Oncorus, Inc. (ONCR) stock price, news, quote & history – Yahoo FinanceDecember 29, 2023 | uk.finance.yahoo.comComera Life Sciences Holdings IncDecember 17, 2023 | investing.comOncorus Inc Ordinary SharesOctober 28, 2023 | morningstar.comMONCR Historical DataOctober 16, 2023 | investing.comWhat's Going On With Oncorus (ONCR) Stock Friday?June 16, 2023 | msn.comSee More Headlines ONCR Stock Analysis - Frequently Asked Questions How were Oncorus' earnings last quarter? Oncorus, Inc. (NASDAQ:ONCR) released its quarterly earnings results on Monday, May, 22nd. The company reported ($1.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.70) by $0.48. When did Oncorus IPO? Oncorus (ONCR) raised $87 million in an initial public offering on Friday, October 2nd 2020. The company issued 5,800,000 shares at $14.00-$16.00 per share. Jefferies, Evercore ISI and Piper Sandler acted as the underwriters for the IPO. What other stocks do shareholders of Oncorus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oncorus investors own include Enterprise Products Partners (EPD), Aeglea BioTherapeutics (AGLE), Athenex (ATNX), Cheniere Energy (LNG), Atreca (BCEL), Fiserv (FI) and Brigham Minerals (MNRL). Company Calendar Last Earnings5/22/2023Today7/16/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:ONCR CIK1671818 Webwww.oncorus.com Phone339-240-3330FaxN/AEmployees64Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.33 per share Price / Book0.05Miscellaneous Outstanding Shares26,090,000Free Float21,633,000Market Cap$3.29 million OptionableOptionable Beta3.60 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:ONCR) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncorus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncorus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.